Evidence map›Paper›PMID 42449506›Full record

ArticleInternational journal of cancer2026

Association Between Socioeconomic Position and Diagnosis, Treatment and Survival of Patients With Stage I-III Rectal Cancer in the Netherlands.

Suzanne E N de Vries, Felice N van Erning, Mieke J Aarts, Alice M Couwenberg, Laskarina J K Galanos, Irene E G van Hellemond, Ignace H J T de Hingh, Robin Lurvink, Iris D Nagtegaal, Johannes H W de Wilt and 1 more

Abstract read
In one paragraph

Article in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Suzanne E N de VriesDepartment of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0002-8788-1810
Felice N van ErningDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.ORCID https://orcid.org/0000-0003-0125-1429
Mieke J AartsDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Alice M CouwenbergDepartment of Radiotherapy, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Laskarina J K GalanosDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Irene E G van HellemondDepartment of Internal Medicine, Catharina Hospital, Eindhoven, the Netherlands.ORCID https://orcid.org/0000-0001-6775-7364
Ignace H J T de HinghDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
Robin LurvinkDepartment of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
Iris D NagtegaalDepartment of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
Johannes H W de WiltDepartment of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.
Marloes A G ElferinkDepartment of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Socioeconomic position (SEP) influences cancer care and outcomes, even in countries with government-funded healthcare. This population-based study examined associations between SEP, rectal cancer care and survival of patients in the Netherlands. Data from 25,995 patients with Stage I-III rectal cancer diagnosed between 2015 and 2023 were obtained from the Netherlands Cancer Registry. SEP was categorised as lower, intermediate or higher using income-based postal code data. Associations between SEP and detection method, treatments, and outcomes were analysed using multivariable logistic regression. Relative survival and relative excess risk (RER) of death were calculated using a generalised linear model. Compared to lower SEP, higher SEP patients were younger (median age 66 vs. 71 years), more often male (65% vs. 59%), had better performance status (71% vs. 52% PS0), fewer comorbidities (63% vs. 50% CCI 0) and lower obesity rates (15% vs. 23%). Higher rates of Stage I tumours (34% vs. 30%), screen-detection (45% vs. 38%), laparoscopic surgery use (93% vs. 90%), and lower rates of colostomies (64% vs. 71%) and adverse in-hospital outcomes (44% vs. 55%) were observed among higher SEP patients (all p < 0.001). Five-year relative survival improved with increasing SEP (79.5% lower, 82.4% intermediate, 84.9% higher SEP; p < 0.001), with lower excess mortality for higher SEP patients (RER 0.90, 95% CI 0.81-0.99). SEP-related differences were observed in screening, stage at diagnosis, surgical treatment and survival. Although several disparities were partly explained by comorbidity and BMI, others persisted, highlighting the need for targeted strategies to reduce differences between SEP groups in rectal cancer management and outcomes.

Indexed as

Rectal NeoplasmsSocial ClassAgedAged, 80 and overFemaleHumansLow Socioeconomic StatusMaleMiddle AgedNeoplasm StagingNetherlandsRegistriesSocioeconomic Disparities in HealthSocioeconomic Factorsdetection moderectal cancerrelative survivalsocioeconomic position (SEP)treatment

Identifiers

PMID42449506
PMCPMC13637065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.